HSBC HOLDINGS PLC - MAXCYTE INC ownership

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of MAXCYTE INC
ValueSharesWeighting
Q3 2023$101,256
-43.7%
32,581
-19.3%
0.00%
Q2 2023$179,741
-81.0%
40,354
-79.3%
0.00%
-100.0%
Q1 2023$943,844
+55.2%
195,229
+72.7%
0.00%0.0%
Q4 2022$608,300
-33.2%
113,067
-19.6%
0.00%0.0%
Q3 2022$910,000
+28.5%
140,717
-7.9%
0.00%0.0%
Q2 2022$708,000
-33.5%
152,859
+1.3%
0.00%0.0%
Q1 2022$1,064,000
-4.3%
150,941
+38.7%
0.00%0.0%
Q4 2021$1,112,000
-11.2%
108,856
+5.5%
0.00%0.0%
Q3 2021$1,252,000103,1500.00%
Other shareholders
MAXCYTE INC shareholders Q4 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 1,885,000$5,881,2005.55%
Vitruvian Partners LLP 5,043,356$15,735,2714.46%
Stonepine Capital Management, LLC 3,761,640$11,736,3173.90%
Mudita Advisors LLP 1,390,858$4,339,4773.17%
RIVER GLOBAL INVESTORS LLP 1,473,254$4,588,3591.07%
Casdin Capital, LLC 1,890,000$5,896,8000.65%
Portolan Capital Management 2,143,666$6,688,2380.62%
Grandeur Peak Global Advisors, LLC 1,434,819$4,476,6350.34%
First Light Asset Management, LLC 1,073,110$3,348,1030.32%
Granahan Investment Management 1,975,847$6,164,6430.22%
View complete list of MAXCYTE INC shareholders